These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19908241)

  • 1. The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells.
    Yan KH; Yao CJ; Chang HY; Lai GM; Cheng AL; Chuang SE
    Mol Carcinog; 2010 Mar; 49(3):235-46. PubMed ID: 19908241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
    Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
    J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW
    Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
    Li M; Lee TW; Yim AP; Mok TS; Chen GG
    J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells.
    Zhu H; Pan X; Qi H; Wang X; Hou S; Han B; Liu Z; Xu L
    Oncol Rep; 2011 Jan; 25(1):81-90. PubMed ID: 21109961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
    Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo.
    Ye X; Zhou W; Li Y; Sun Y; Zhang Y; Ji H; Lai Y
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):277-85. PubMed ID: 20352217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin antagonizes the cytotoxic effect of methotrexate in lung cancer cells.
    Yan KH; Lee LM; Hsieh MC; Yan MD; Yao CJ; Chang PY; Chen TL; Chang HY; Cheng AL; Lai GM; Chuang SE
    Oncol Rep; 2013 Sep; 30(3):1497-505. PubMed ID: 23799623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ligands of peroxisome proliferator-activated receptor (PPAR) gamma inhibit growth of human esophageal carcinoma cells through induction of apoptosis and cell cycle arrest.
    Fujii D; Yoshida K; Tanabe K; Hihara J; Toge T
    Anticancer Res; 2004; 24(3a):1409-16. PubMed ID: 15274302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells.
    Colin-Cassin C; Yao X; Cerella C; Chbicheb S; Kuntz S; Mazerbourg S; Boisbrun M; Chapleur Y; Diederich M; Flament S; Grillier-Vuissoz I
    Mol Carcinog; 2015 May; 54(5):393-404. PubMed ID: 24293218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand.
    Nonaka M; Tazuma S; Hyogo H; Kanno K; Chayama K
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e198-206. PubMed ID: 17868335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells.
    Vitale G; Zappavigna S; Marra M; Dicitore A; Meschini S; Condello M; Arancia G; Castiglioni S; Maroni P; Bendinelli P; Piccoletti R; van Koetsveld PM; Cavagnini F; Budillon A; Abbruzzese A; Hofland LJ; Caraglia M
    Biotechnol Adv; 2012; 30(1):169-84. PubMed ID: 21871555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
    Takenokuchi M; Saigo K; Nakamachi Y; Kawano S; Hashimoto M; Fujioka T; Koizumi T; Tatsumi E; Kumagai S
    Acta Haematol; 2006; 116(1):30-40. PubMed ID: 16809887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
    Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells.
    Yoshida K; Tanabe K; Fujii D; Oue N; Yasui W; Toge T
    Anticancer Res; 2003; 23(1A):267-73. PubMed ID: 12680223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis.
    Tsubouchi Y; Sano H; Kawahito Y; Mukai S; Yamada R; Kohno M; Inoue K; Hla T; Kondo M
    Biochem Biophys Res Commun; 2000 Apr; 270(2):400-5. PubMed ID: 10753637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.